| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/06/2011 | CN101181263B Treatment of respiratory diseases |
| 07/06/2011 | CN101119986B Optically active tetrahydronaphthalene derivative |
| 07/06/2011 | CN101052397B 2-sulfanyl-benzimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 07/06/2011 | CN101048408B Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 07/05/2011 | US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/05/2011 | US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse |
| 07/05/2011 | US7972629 Product comprising a combination of milk serum apoproteins and free fatty acids |
| 07/05/2011 | US7972624 Method of manufacturing modified release dosage forms |
| 07/05/2011 | CA2634055C Antitussive agent |
| 07/05/2011 | CA2555064C A pharmaceutical composition |
| 07/05/2011 | CA2533434C Artificial cpg single-stranded oligodeoxynucleotide and antiviral use thereof |
| 07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 07/05/2011 | CA2475867C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/05/2011 | CA2461625C Use of irbesartan for the preparation of medicinal products that are useful for preventing or treating pulmonary hypertension |
| 07/05/2011 | CA2405767C Pharmaceutical formulations for dry powder inhalers |
| 07/05/2011 | CA2401491C Ccr4-binding antibody and diagnostic and therapeutic uses thereof |
| 06/30/2011 | WO2011079103A1 Spiropiperidine benzylamines as beta-tryptase inhibitors |
| 06/30/2011 | WO2011079051A1 Fused heteroaromatic pyrrolidinones as syk inhibitors |
| 06/30/2011 | WO2011078984A1 [4[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1h-pyrrolo-pyridin-yl)-methanones and synthesis thereof |
| 06/30/2011 | WO2011078823A1 Compositions containing salmeterol, fluticasone and cromoglicic acid |
| 06/30/2011 | WO2011078818A1 Dry powder combination of tiotropium, a corticosteroid and a cromoglicic acid derivative |
| 06/30/2011 | WO2011078817A1 Combination of tiotropium, mometasone and a cromoglicic acid derivative in dry powder form |
| 06/30/2011 | WO2011078816A1 Dry powder combination of tiotropium, formoterol and a cromoglicic acid derivative |
| 06/30/2011 | WO2011078815A1 Dry powder combination of tiotropium, budesonide and a cromoglicic acid derivative |
| 06/30/2011 | WO2011078413A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/30/2011 | WO2011078303A1 Aminopyridine compound |
| 06/30/2011 | WO2011078221A1 Imidazopyridazine compounds |
| 06/30/2011 | WO2011078143A1 Pyrimidine derivatives and pharmaceutical composition containing same |
| 06/30/2011 | WO2011077800A1 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages |
| 06/30/2011 | WO2011077587A1 Composition for inhibiting allergic diseases |
| 06/30/2011 | WO2011076781A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy |
| 06/30/2011 | WO2011076391A1 Conjugate with target-finding ligand and use thereof |
| 06/30/2011 | WO2011017350A3 Compounds as lysophosphatidic acid receptor antagonists |
| 06/30/2011 | US20110160303 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
| 06/30/2011 | US20110160291 Oligonucleotide Compositions and Their Use to Induce Apoptosis |
| 06/30/2011 | US20110160268 Compositions and methods for treating lung disorders |
| 06/30/2011 | US20110160249 5-lipoxygenase-activating protein inhibitor |
| 06/30/2011 | US20110160241 New peptidomimetic compounds |
| 06/30/2011 | US20110160235 Triazolyl tropane derivatives |
| 06/30/2011 | US20110160234 Tricyclic Compounds as Modulators of TNF-alpha Synthesis and as PDE4 Inhibitors |
| 06/30/2011 | US20110160232 Certain chemical entities and therapeutic uses thereof |
| 06/30/2011 | US20110160217 Deuterium enriched analogues of tadalafil as pde5 inhibitors |
| 06/30/2011 | US20110160215 Substituted Triazolo-Pyrazine Compounds |
| 06/30/2011 | US20110160207 Heterocyclic amide compounds useful as kinase inhibitors |
| 06/30/2011 | US20110160205 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 06/30/2011 | US20110160193 New Benzothiazinone Derivatives and Their Use as Antibacterial Agents |
| 06/30/2011 | US20110160187 3-aryl-5,6-disubstituted pyridazines |
| 06/30/2011 | US20110160181 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 06/30/2011 | US20110160171 Treatment of congestion using steroids and adrenergics |
| 06/30/2011 | US20110160167 Steroid Derivatives Acting As Glucocorticosteroid Receptor Agonists |
| 06/30/2011 | US20110160164 Compounds for nonsense suppression and methods for their use |
| 06/30/2011 | US20110160163 INHIBITORS OF p38 |
| 06/30/2011 | US20110160162 Prodrugs of a2b adenosine receptor antagonists |
| 06/30/2011 | US20110160120 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110159098 Stabilization and delivery of nucleic acid complexes |
| 06/30/2011 | US20110159079 High Delivery Rates for Lipid Based Drug Formulations, and Methods of Treatment Thereof |
| 06/30/2011 | US20110159048 Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications |
| 06/30/2011 | US20110159030 Mucosal combination vaccines for bacterial meningitis |
| 06/30/2011 | US20110159003 Ligands That Bind Il-4 and/or Il-13 |
| 06/30/2011 | US20110158968 Methods of making enhanced, autologous fat grafts |
| 06/30/2011 | US20110158943 Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof |
| 06/30/2011 | US20110158939 Methods and Compositions for Treating Asthma in Human and Nonhuman Primates |
| 06/30/2011 | US20110158906 Targeted block copolymer micelles |
| 06/30/2011 | CA2786950A1 Fused heteroaromatic pyrrolidinones as syk inhibitors |
| 06/30/2011 | CA2785668A1 Aminopyridine compound |
| 06/30/2011 | CA2785439A1 [4[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1h-pyrrolo-pyridin-yl)-methanones and synthesis thereof |
| 06/30/2011 | CA2785139A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy |
| 06/30/2011 | CA2784705A1 Conjugate with target-finding ligand and use thereof |
| 06/30/2011 | CA2784180A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/29/2011 | EP2338520A1 Conjugate with targeting ligand and use of same |
| 06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/29/2011 | EP2338512A1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 06/29/2011 | EP2338497A1 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 06/29/2011 | EP2338489A1 Method of providing pirfenidone therapy to a patient |
| 06/29/2011 | EP2337569A2 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota |
| 06/29/2011 | EP2200603B1 Osmolytes for the treatment of allergic respiratory diseases |
| 06/29/2011 | EP1755606B2 Quinazolinone derivatives useful as vanilloid antagonists |
| 06/29/2011 | EP1379225B1 Novel medicament compositions based on anticholinergic agents and endothelin antagonists |
| 06/29/2011 | CN1883530B Laggera extracts with anti-virus, anti-inflammation and/or antibiotic functions and use thereof |
| 06/29/2011 | CN1812974B N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-N-hydroxyformamide compounds as metalloproteinase inhibitors |
| 06/29/2011 | CN102112495A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112494A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112474A Quinuclidine carbonate derivatives and medicinal composition thereof |
| 06/29/2011 | CN102112473A Pyrrolidinyl-alkyl-amide derivatives, their preparation and their therapeutic application as ccr3 receptor ligands |
| 06/29/2011 | CN102112462A Aminopropylidene derivative |
| 06/29/2011 | CN102112449A Phenyl or pyridinyl substituted indazoles derivatives |
| 06/29/2011 | CN102112149A Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases |
| 06/29/2011 | CN102112130A Pyrazine derivatives as epithelial sodium channel blockers |
| 06/29/2011 | CN102108356A Novel promoter and virus vector containing same |
| 06/29/2011 | CN102108346A Method for preparing lysozyme |
| 06/29/2011 | CN102108336A Recombinant adenovirus vaccine containing EB (Epstein-Barr) virus membrane protein gp350/220, gp85, gp78 or gp25 gene |
| 06/29/2011 | CN102106995A Chinese medicine preparation for treating recurrent respiratory tract infection of pediatric patient with chronic idiopathic thrombocytopenic purpura |
| 06/29/2011 | CN102106976A Traditional Chinese medicine preparation for treating infantile repeated cold caused by lung/spleen qi deficiency |
| 06/29/2011 | CN102106968A Process for carrying out impurity removal on syrup technical extract for nourishing yin to clear away lung-heat by flocculation and subsequent separation |
| 06/29/2011 | CN102106960A Oropharynx spray |
| 06/29/2011 | CN102106929A Chinese medicinal composition for treating nasal sinuitis |
| 06/29/2011 | CN102106928A Method for preparing high-purity oil tea saponins |
| 06/29/2011 | CN102106914A Medicament for treating infectious diseases, preparation method and application thereof |
| 06/29/2011 | CN102106907A Quality control method for rhubarb (traditional Chinese medicine) ethanol-extraction process |